欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/5834/001
药品名称Pomalidomide Sandoz 1 mg, hard capsules
活性成分
    • pomalidomide 1.0 mg
剂型Capsule, hard
上市许可持有人Sandoz B.V. Veluwezoom 22 1327 AH Almere The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Pomalidomide Sandoz 1 mg, harde capsules
互认成员国 - 产品名称
    • Denmark (DK)
      Pomalidomide "Sandoz"
    • Latvia (LV)
    • Iceland (IS)
    • Lithuania (LT)
      Pomalidomide Sandoz 1 mg kietosios kapsulės
    • Ireland (IE)
    • Estonia (EE)
    • Austria (AT)
    • Hungary (HU)
      Pomalidomide Sandoz
    • France (FR)
    • Cyprus (CY)
      Pomalidomide/Sandoz 1mg hard capsules
    • Spain (ES)
    • Czechia (CZ)
      Pomalidomid Sandoz
    • Italy (IT)
    • Romania (RO)
    • Greece (GR)
    • Slovakia (SK)
    • Sweden (SE)
    • Slovenia (SI)
    • Norway (NO)
    • Malta (MT)
    • Finland (FI)
    • Germany (DE)
      Pomalidomid HEXAL 1 mg Hartkapseln
    • Poland (PL)
许可日期2024/06/07
最近更新日期2025/07/07
药物ATC编码
    • L04AX06 pomalidomide
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase